RETRACTED, A. EFFICACY AND SAFETY OF ADALIMUMAB VERSUS INFLIXIMAB IN PATIENTS SUFFERED FROM MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS. Asian Journal of Pharmaceutical and Clinical Research, [S. l.], v. 10, n. 3, p. 300–307, 2017. Disponível em: https://journals.innovareacademics.in/index.php/ajpcr/article/view/16213. Acesso em: 15 may. 2024.